Clinical trials - Press Releases

Date	Title	Company
05-Apr-2021	Best Clinical Research Courses and Pharmacovigilance Training in Pune	Clariwell Global Services
05-Apr-2021	Risk Invovled In Clinical Trial for Clinical Research	Clariwell Global Services LLP
01-Apr-2021	Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study	BioNTech
01-Apr-2021	Auxita and MyMeds&Me Announce Strategic Partnership to Deliver Integrated Digital Pharmacovigilance Capabilities	MyMeds&Me
01-Apr-2021	Medical Perfusion Technology Market by Technology Trends 2021 - XVIVO Perfusion, OrganOx Limited, TransMedics, Organ Recovery Systems, Xenios AG	theinsightpartners
01-Apr-2021	Microplate Reader Market Outlook and Business Opportunities 2020-2027 - BMG Labtech, Hercuvan Lab Systems, Molecular Devices	theinsightpartners
31-Mar-2021	Panthera is running a Ph 3 trial for AstraZeneca’s monoclonal antibody combination to reduce the effects of COVID-19 in patients with the virus from its North Manchester site	Panthera Biopartners
31-Mar-2021	Pharmaxis Announces World First Clinical Trial of Treatment to Prevent Wound and Burns Scars	Pharmaxis
30-Mar-2021	Reltio Launches Enterprise 360 Site Intelligence to Accelerate Clinical Trials	Reltio
30-Mar-2021	Formedix Launches All-in-One Cloud-Based Clinical Metadata Repository and Study Automation Platform to Simplify and Expedite Clinical Trial Design and Build	Formedix
30-Mar-2021	Lilly, Vir Biotechnology and GSK announce positive topline data from the phase 2 BLAZE-4 trial evaluating bamlanivimab with VIR-7831 in low-risk adults with COVID-19	GSK
29-Mar-2021	gaitQ Awarded Grant by the UK’s National Institute for Health Research for the continued development of its system	gaitQ
29-Mar-2021	Autolus Therapeutics Announces Updated Manufacturing Facility Strategy Leveraging its UK Operations	Autolus Therapeutics plc
29-Mar-2021	The PROTECT-V trial investigating UNIONs COVID-19 candidate receives Urgent Public Health Prioritization from the UK government	UNION therapeutics A/S
29-Mar-2021	HUTCHMED Initiates International Phase I Trials of IDH1/2 Dual Inhibitor in Patients with Advanced Solid Tumors or Hematological Malignancies	HUTCHMED
29-Mar-2021	OKYO Pharma Limited ("OKYO" or the "Company") - OKYO announces appointment of Dr Rajkumar Patil as Chief Scientific Officer	OKYO Pharma Limited
29-Mar-2021	Syncona cornerstones $148 million Series C Financing in Gyroscope	Syncona Ltd
29-Mar-2021	Vertex Receives Australian TGA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat People With Cystic Fibrosis Ages 12 Years and Older Who Have At Least One F508del Mutation	Vertex Pharmaceuticals Incorporated
29-Mar-2021	Avifavir obtains its first registration in Asia	Russian Direct Investment Fund
29-Mar-2021	HUTCHMED Initiates a Phase Ib/II Trial of Surufatinib in Combination with Tislelizumab in Patients with Advanced Solid Tumors	Hutchison China MediTech Limited